# Esketamine Combined With PRF of DRG for Acute/Subacute Zoster-associated Pain

> **NCT06914206** · NA · NOT_YET_RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 184 (estimated)

## Conditions studied

- Herpes Zoster

## Interventions

- **DRUG:** esketamine group
- **DRUG:** PRF group

## Key facts

- **NCT ID:** NCT06914206
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04-01
- **Primary completion:** 2026-04-01
- **Final completion:** 2026-07-01
- **Target enrollment:** 184 (ESTIMATED)
- **Last updated:** 2025-04-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06914206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06914206, "Esketamine Combined With PRF of DRG for Acute/Subacute Zoster-associated Pain". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06914206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*